You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Neurosci., 08 January 2024

Sec. Sleep and Circadian Rhythms

Volume 17 - 2023 | https://doi.org/10.3389/fnins.2023.1344915

Corrigendum: Case report: A patient with Delayed Sleep-Wake Phase Disorder and Optic Nerve Hypoplasia treated with tasimelteon: a case study

    SP

    Sandra P. Smieszek 1*

    AR

    Alyssa R. Kaden 1

    CE

    Caroline E. Johnson 1

    JL

    Jennifer L. Brzezynski 1

    CX

    Changfu Xiao 1

    CM

    Christos M. Polymeropoulos 1

    GB

    Gunther Birznieks 1

    HA

    Helene A. Emsellem 2,3

    MH

    Mihael H. Polymeropoulos 1

  • 1. Vanda Pharmaceuticals Inc., Washington, DC, United States

  • 2. The Center for Sleep & Wake Disorders, Chevy Chase, MD, United States

  • 3. Department of Neurology, George Washington University, Washington, DC, United States

Article metrics

View details

836

Views

527

Downloads

In the published article, there was an error. (There was an omission).

A correction has been made to Discussion, Paragraph 4. This sentence previously stated:

“This participant is not a carrier of the variable number of tandem repeat (VNTR) PER34/4 genotype, associated with delayed sleep patterns, nor the CRY1 splicing variant (Patke et al., 2017). No other predicted loss-of-function mutations within circadian genes were identified.”

The corrected sentence appears below:

“This participant is not a carrier of the variable number of tandem repeat (VNTR) PER34/4 genotype, associated with delayed sleep patterns, nor the CRY1 splicing variant (Patke et al., 2017). This patient has been determined to carry two 5′ UTR region variants in the Atonal BHLH Transcription Factor 7 (ATOH7) gene known to be associated with ONH, rs61854782 and rs7916697. ATOH7 is expressed in retinal progenitor cells and has a crucial role in retinal ganglion cell development. No other predicted loss-of-function mutations within circadian genes were identified.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

  • 1

    Patke A. Murphy P. Onat O. Krieger A. Özçelik T. Campbell S. et al . (2017). Mutation of the human circadian clock gene CRY1 in familial delayed sleep phase disorder. Cell169, 203215.e1. 10.1016/j.cell.2017.03.027

Summary

Keywords

biological rhythms, circadian rhythm disorders, clinical trials research, sleep/wake mechanisms, Delayed Sleep-Wake Phase Disorder, delayed sleep, night owl, Optic Nerve Hypoplasia

Citation

Smieszek SP, Kaden AR, Johnson CE, Brzezynski JL, Xiao C, Polymeropoulos CM, Birznieks G, Emsellem HA and Polymeropoulos MH (2024) Corrigendum: Case report: A patient with Delayed Sleep-Wake Phase Disorder and Optic Nerve Hypoplasia treated with tasimelteon: a case study. Front. Neurosci. 17:1344915. doi: 10.3389/fnins.2023.1344915

Received

27 November 2023

Accepted

18 December 2023

Published

08 January 2024

Volume

17 - 2023

Edited and reviewed by

Melissa A. St. Hilaire, Merrimack College, United States

Updates

Copyright

*Correspondence: Sandra P. Smieszek

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics